| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | modified amino acid binding | 9.97e-05 | 122 | 121 | 6 | GO:0072341 | |
| GeneOntologyMolecularFunction | syntaxin binding | 1.87e-04 | 87 | 121 | 5 | GO:0019905 | |
| GeneOntologyMolecularFunction | glucokinase activity | 3.60e-04 | 5 | 121 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 3.60e-04 | 5 | 121 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 3.60e-04 | 5 | 121 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 4.81e-04 | 60 | 121 | 4 | GO:0005544 | |
| GeneOntologyMolecularFunction | clathrin binding | 5.80e-04 | 63 | 121 | 4 | GO:0030276 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 1.34e-05 | 25 | 122 | 4 | GO:0048791 | |
| GeneOntologyCellularComponent | RNA cap binding complex | 2.48e-06 | 17 | 122 | 4 | GO:0034518 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 4F complex | 5.31e-05 | 13 | 122 | 3 | GO:0016281 | |
| GeneOntologyCellularComponent | NatA complex | 3.34e-04 | 5 | 122 | 2 | GO:0031415 | |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 3.34e-04 | 5 | 122 | 2 | GO:0035658 | |
| GeneOntologyCellularComponent | neuromuscular junction | 5.08e-04 | 112 | 122 | 5 | GO:0031594 | |
| MousePheno | decreased skeletal muscle size | 1.50e-05 | 81 | 92 | 6 | MP:0010240 | |
| MousePheno | abnormal skeletal muscle size | 3.32e-05 | 93 | 92 | 6 | MP:0009458 | |
| Domain | MA3 | 5.10e-06 | 6 | 120 | 3 | SM00544 | |
| Domain | MA3 | 5.10e-06 | 6 | 120 | 3 | PF02847 | |
| Domain | Initiation_fac_eIF4g_MI | 5.10e-06 | 6 | 120 | 3 | IPR003891 | |
| Domain | MI | 5.10e-06 | 6 | 120 | 3 | PS51366 | |
| Domain | eIF5C | 8.88e-06 | 7 | 120 | 3 | SM00515 | |
| Domain | W2 | 8.88e-06 | 7 | 120 | 3 | PF02020 | |
| Domain | W2 | 8.88e-06 | 7 | 120 | 3 | PS51363 | |
| Domain | W2_domain | 8.88e-06 | 7 | 120 | 3 | IPR003307 | |
| Domain | MIF4G | 3.00e-05 | 10 | 120 | 3 | SM00543 | |
| Domain | MIF4G | 3.00e-05 | 10 | 120 | 3 | PF02854 | |
| Domain | MIF4G-like_typ-3 | 3.00e-05 | 10 | 120 | 3 | IPR003890 | |
| Domain | Synaptotagmin1 | 4.09e-05 | 2 | 120 | 2 | IPR015428 | |
| Domain | NatA_aux_su | 4.09e-05 | 2 | 120 | 2 | IPR021183 | |
| Domain | DUF1712 | 4.09e-05 | 2 | 120 | 2 | PF08217 | |
| Domain | NARP1 | 4.09e-05 | 2 | 120 | 2 | PF12569 | |
| Domain | DUF1712_fun | 4.09e-05 | 2 | 120 | 2 | IPR013176 | |
| Domain | - | 1.11e-04 | 15 | 120 | 3 | 1.25.40.180 | |
| Domain | MIF4-like | 1.11e-04 | 15 | 120 | 3 | IPR016021 | |
| Domain | tRNAsynth_Ia_anticodon-bd | 1.11e-04 | 15 | 120 | 3 | IPR009080 | |
| Domain | KAZAL_1 | 1.97e-04 | 18 | 120 | 3 | PS00282 | |
| Domain | Prot_kin_PKC_delta | 2.44e-04 | 4 | 120 | 2 | IPR014376 | |
| Domain | Synaptotagmin | 2.72e-04 | 20 | 120 | 3 | IPR001565 | |
| Domain | C2 | 3.12e-04 | 142 | 120 | 6 | PS50004 | |
| Domain | - | 3.89e-04 | 148 | 120 | 6 | 2.60.40.150 | |
| Domain | Hexokinase_2 | 4.04e-04 | 5 | 120 | 2 | PF03727 | |
| Domain | Hexokinase_BS | 4.04e-04 | 5 | 120 | 2 | IPR019807 | |
| Domain | Hexokinase_C | 4.04e-04 | 5 | 120 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 4.04e-04 | 5 | 120 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 4.04e-04 | 5 | 120 | 2 | PF00349 | |
| Domain | HEXOKINASE_2 | 4.04e-04 | 5 | 120 | 2 | PS51748 | |
| Domain | HEXOKINASE_1 | 4.04e-04 | 5 | 120 | 2 | PS00378 | |
| Domain | AGC-kinase_C | 4.60e-04 | 56 | 120 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 4.60e-04 | 56 | 120 | 4 | PS51285 | |
| Domain | S_TK_X | 4.60e-04 | 56 | 120 | 4 | SM00133 | |
| Domain | Keratin_2_head | 4.74e-04 | 24 | 120 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 4.74e-04 | 24 | 120 | 3 | PF16208 | |
| Domain | Keratin_II | 6.04e-04 | 26 | 120 | 3 | IPR003054 | |
| Domain | Hexokinase | 6.04e-04 | 6 | 120 | 2 | IPR001312 | |
| Domain | CPSASE_2 | 6.04e-04 | 6 | 120 | 2 | PS00867 | |
| Domain | C2_dom | 6.70e-04 | 164 | 120 | 6 | IPR000008 | |
| Domain | TPR_REGION | 6.91e-04 | 165 | 120 | 6 | PS50293 | |
| Domain | TPR | 6.91e-04 | 165 | 120 | 6 | PS50005 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 8.42e-04 | 7 | 120 | 2 | IPR005479 | |
| Domain | BC-like_N | 8.42e-04 | 7 | 120 | 2 | IPR005481 | |
| Domain | CPSase_L_D2 | 8.42e-04 | 7 | 120 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 8.42e-04 | 7 | 120 | 2 | PF00289 | |
| Domain | C2 | 1.57e-03 | 131 | 120 | 5 | PF00168 | |
| Domain | Kazal_2 | 1.58e-03 | 36 | 120 | 3 | PF07648 | |
| Domain | Pkinase_C | 1.71e-03 | 37 | 120 | 3 | IPR017892 | |
| Domain | C2 | 1.92e-03 | 137 | 120 | 5 | SM00239 | |
| Domain | STAS | 2.17e-03 | 11 | 120 | 2 | PS50801 | |
| Domain | STAS | 2.17e-03 | 11 | 120 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 2.17e-03 | 11 | 120 | 2 | IPR001902 | |
| Domain | STAS_dom | 2.17e-03 | 11 | 120 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 2.17e-03 | 11 | 120 | 2 | IPR011547 | |
| Domain | - | 2.17e-03 | 11 | 120 | 2 | 1.10.730.10 | |
| Domain | - | 2.17e-03 | 11 | 120 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 2.17e-03 | 11 | 120 | 2 | PF00916 | |
| Domain | - | 2.21e-03 | 207 | 120 | 6 | 1.25.40.10 | |
| Domain | Pkinase_C | 2.47e-03 | 42 | 120 | 3 | PF00433 | |
| Domain | TPR_1 | 2.71e-03 | 90 | 120 | 4 | IPR001440 | |
| Domain | TPR_1 | 2.71e-03 | 90 | 120 | 4 | PF00515 | |
| Domain | - | 3.05e-03 | 13 | 120 | 2 | 3.40.50.20 | |
| Domain | KAZAL | 3.21e-03 | 46 | 120 | 3 | SM00280 | |
| Domain | ATP_GRASP | 3.54e-03 | 14 | 120 | 2 | PS50975 | |
| Domain | ATP-grasp | 3.54e-03 | 14 | 120 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 3.54e-03 | 14 | 120 | 2 | IPR016185 | |
| Domain | TPR-like_helical_dom | 3.96e-03 | 233 | 120 | 6 | IPR011990 | |
| Domain | KAZAL_2 | 4.07e-03 | 50 | 120 | 3 | PS51465 | |
| Domain | TPR_2 | 4.07e-03 | 50 | 120 | 3 | PF07719 | |
| Domain | TPR_2 | 4.07e-03 | 50 | 120 | 3 | IPR013105 | |
| Domain | - | 4.07e-03 | 15 | 120 | 2 | 3.30.1490.20 | |
| Domain | Kazal_dom | 4.30e-03 | 51 | 120 | 3 | IPR002350 | |
| Domain | WAP | 4.63e-03 | 16 | 120 | 2 | SM00217 | |
| Domain | WAP | 4.63e-03 | 16 | 120 | 2 | PF00095 | |
| Domain | - | 5.23e-03 | 17 | 120 | 2 | 4.10.75.10 | |
| Domain | WAP | 5.23e-03 | 17 | 120 | 2 | PS51390 | |
| Domain | aa-tRNA-synth_I_CS | 5.86e-03 | 18 | 120 | 2 | IPR001412 | |
| Domain | ATP_grasp_subdomain_1 | 5.86e-03 | 18 | 120 | 2 | IPR013815 | |
| Domain | - | 5.86e-03 | 18 | 120 | 2 | 3.30.470.20 | |
| Domain | KU | 5.86e-03 | 18 | 120 | 2 | SM00131 | |
| Domain | - | 5.86e-03 | 18 | 120 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 5.86e-03 | 18 | 120 | 2 | IPR020901 | |
| Domain | C1_1 | 5.88e-03 | 57 | 120 | 3 | PF00130 | |
| Domain | Ion_trans_dom | 6.28e-03 | 114 | 120 | 4 | IPR005821 | |
| Domain | Ion_trans | 6.28e-03 | 114 | 120 | 4 | PF00520 | |
| Pathway | BIOCARTA_IRES_PATHWAY | 1.15e-05 | 7 | 99 | 3 | M22028 | |
| Pathway | BIOCARTA_MTOR_PATHWAY | 1.52e-05 | 22 | 99 | 4 | M16563 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 2.18e-05 | 24 | 99 | 4 | M4791 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT6A KRT6B RANBP2 NAA15 HK2 RARS1 SPTAN1 LARS1 UNC45A CPS1 KRR1 MDH2 SLC25A22 PARP1 RUVBL1 KRT6C SYNE2 POP1 EIF4G1 EIF4G2 ECI2 NMT1 SNRPG | 1.05e-09 | 1415 | 124 | 23 | 28515276 |
| Pubmed | KRT6A MYH4 KRT6B RANBP2 ABCB5 SPTAN1 GRK5 DNAH2 HKDC1 CHD3 MDH2 SLC25A22 PARP1 LATS1 GUCY1A2 KRT6C RNPS1 SYNE2 EIF4G1 EIF4G3 HSPA2 PCID2 CFAP46 | 1.50e-09 | 1442 | 124 | 23 | 35575683 | |
| Pubmed | eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. | 2.30e-09 | 6 | 124 | 4 | 18426977 | |
| Pubmed | RANBP2 RARS1 SPTAN1 LARS1 IDH1 UNC45A MDH2 TRIP4 SLC25A22 CRYL1 PARP1 IGBP1 LATS1 AKAP9 RUVBL1 RNPS1 POP1 EIF4G1 EIF4G2 RASSF8 PCID2 | 3.32e-09 | 1247 | 124 | 21 | 27684187 | |
| Pubmed | eIF4G is required for the pioneer round of translation in mammalian cells. | 1.91e-08 | 9 | 124 | 4 | 15361857 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RANBP2 HK2 RARS1 SPTAN1 LARS1 CHD3 GATAD2B PARP1 RUVBL1 EIF4G1 EIF4G2 | 3.30e-08 | 332 | 124 | 11 | 32786267 |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 29357356 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 7543104 | ||
| Pubmed | 7.02e-08 | 59 | 124 | 6 | 32382008 | ||
| Pubmed | NAA15 HK2 SPTAN1 LARS1 CHD3 CHD1L IDH1 PARP1 ARL2 RUVBL1 MTOR EIF4G1 EIF4G2 | 7.23e-08 | 538 | 124 | 13 | 28524877 | |
| Pubmed | KRT6B RANBP2 HK2 RARS1 SPTAN1 LARS1 CHD3 NCBP2 PARP1 RUVBL1 KRT6C RNPS1 EIF4G1 EIF4G2 | 7.67e-08 | 641 | 124 | 14 | 36057605 | |
| Pubmed | KRT6A RARS1 ANXA6 SPTAN1 CHD3 CHD1L UNC45A KRR1 MDH2 TRIP4 NCBP2 PARP1 ARL2 AKAP9 RUVBL1 RNPS1 POP1 EIF4G1 TRPM1 NMT1 | 8.67e-08 | 1371 | 124 | 20 | 36244648 | |
| Pubmed | KRT6A KRT6B RARS1 GLB1L LARS1 FSTL4 CHD3 KRR1 MDH2 GATAD2B NCBP2 PARP1 RUVBL1 KRT6C POP1 ZW10 HSPA2 SNRPG | 1.53e-07 | 1153 | 124 | 18 | 29845934 | |
| Pubmed | A Synaptotagmin Isoform Switch during the Development of an Identified CNS Synapse. | 1.76e-07 | 4 | 124 | 3 | 27210552 | |
| Pubmed | RANBP2 HK2 PSMG3 ANXA6 SPTAN1 LARS1 UNC45A MCCC1 KRR1 MDH2 HPSE CLCC1 PARP1 MTOR SYNE2 POP1 EIF4G1 EIF4G2 ZW10 HSPA2 | 1.90e-07 | 1440 | 124 | 20 | 30833792 | |
| Pubmed | 1.94e-07 | 312 | 124 | 10 | 37120454 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | RANBP2 NAA15 HK2 RARS1 LARS1 DNAH2 UNC45A CLCC1 SLC25A22 VPS52 MTOR EIF4G1 EIF4G2 ZW10 EIF4G3 HSPA2 | 2.62e-07 | 942 | 124 | 16 | 31073040 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | KRT6B RANBP2 NAA15 HK2 RARS1 SPTAN1 LARS1 CHD1L UNC45A MCCC1 KRR1 SLC25A22 PARP1 RUVBL1 RNPS1 POP1 EIF4G1 EIF4G2 PCID2 | 3.38e-07 | 1353 | 124 | 19 | 29467282 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | NAA15 RARS1 ANXA6 SPTAN1 LARS1 DNAH2 HKDC1 CHD3 MDH2 PARP1 RUVBL1 EIF4G1 EIF4G3 HSPA2 SNRPG | 3.78e-07 | 847 | 124 | 15 | 35235311 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANBP2 ANXA6 BSDC1 UNC45A MCCC1 TEX9 CLCC1 VPS52 LATS1 RUVBL1 EIF4G2 RASSF8 NMT1 HSPA2 PCID2 | 4.13e-07 | 853 | 124 | 15 | 28718761 |
| Pubmed | Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. | 4.40e-07 | 5 | 124 | 3 | 9878069 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 20301457 | ||
| Pubmed | RANBP2 NAA15 RARS1 SPTAN1 LARS1 UNC45A PARP1 RUVBL1 MTOR EIF4G1 EIF4G2 ZW10 HSPA2 | 5.03e-07 | 638 | 124 | 13 | 33239621 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH4 RANBP2 RARS1 SPTAN1 CCDC80 UNC45A MDH2 SORCS1 NCBP2 RUVBL1 MTOR ECI2 ZW10 | 5.89e-07 | 647 | 124 | 13 | 26618866 |
| Pubmed | RANBP2 NAA15 HK2 RARS1 SPTAN1 BSDC1 MCCC1 SLC1A2 GATAD2B RUVBL1 SPHKAP EIF4G2 SLC39A6 SYT1 EIF4G3 HSPA2 UNC13A | 6.52e-07 | 1139 | 124 | 17 | 36417873 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 HK2 RARS1 ANXA6 SPTAN1 LARS1 UNC45A KRR1 MDH2 LAP3 SLC25A22 PARP1 RAB9A RUVBL1 RNPS1 MTOR EIF4G1 EIF4G2 KIF3C | 7.37e-07 | 1425 | 124 | 19 | 30948266 |
| Pubmed | 8.78e-07 | 6 | 124 | 3 | 8626542 | ||
| Pubmed | 8.78e-07 | 6 | 124 | 3 | 10022874 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | KRT6B RANBP2 RARS1 LARS1 CHD1L MCCC1 KRR1 LAP3 NCBP2 PARP1 ARL2 VPS52 RUVBL1 RNPS1 POP1 EIF4G1 PRKCQ PCID2 | 1.06e-06 | 1318 | 124 | 18 | 30463901 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 NAA15 LARS1 CHD3 IDH1 UNC45A MCCC1 MDH2 PARP1 IGBP1 RUVBL1 RNPS1 EIF4G2 EIF4G3 NMT1 | 1.28e-06 | 934 | 124 | 15 | 33916271 |
| Pubmed | 1.32e-06 | 298 | 124 | 9 | 30737378 | ||
| Pubmed | 1.53e-06 | 7 | 124 | 3 | 11331597 | ||
| Pubmed | KRT6B RANBP2 NAA15 KMT2B RARS1 SPTAN1 IDH1 PARP1 RUVBL1 EIF4G1 ECI2 NMT1 PCID2 | 1.68e-06 | 711 | 124 | 13 | 33022573 | |
| Pubmed | 1.75e-06 | 101 | 124 | 6 | 26949739 | ||
| Pubmed | RANBP2 RARS1 ANXA6 LARS1 GATAD2B PARP1 LATS1 RUVBL1 POP1 EIF4G2 | 1.80e-06 | 399 | 124 | 10 | 37536630 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | SPTAN1 SYT2 MCCC1 MDH2 SLC1A2 GATAD2B SLC25A22 MTOR SYT1 PRKCE SYT5 HSPA2 | 2.45e-06 | 621 | 124 | 12 | 22794259 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | COL3A1 KRT6A KRT6B NAA15 RARS1 SPTAN1 LARS1 LAMA3 UNC45A KRR1 SLC25A22 PARP1 RUVBL1 RNPS1 POP1 EIF4G1 NMT1 | 2.48e-06 | 1257 | 124 | 17 | 36526897 |
| Pubmed | RANBP2 POGLUT3 RARS1 ANXA6 SPTAN1 LARS1 IDH1 MCCC1 MDH2 LAP3 PARP1 EIF4G2 HSPA2 ARHGAP19 | 2.50e-06 | 859 | 124 | 14 | 31536960 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NAA15 SPTAN1 UNC45A MCCC1 LATS1 AKAP9 MTOR SYNE2 EIF4G1 PRKCE RASSF8 EIF4G3 BICC1 ARHGAP19 | 2.57e-06 | 861 | 124 | 14 | 36931259 |
| Pubmed | 2.95e-06 | 245 | 124 | 8 | 21182205 | ||
| Pubmed | 3.05e-06 | 330 | 124 | 9 | 32529326 | ||
| Pubmed | MPV17 SPTAN1 LARS1 DNAH2 UNC45A MDH2 SORCS1 SLC25A22 PARP1 RUVBL1 SYNE2 EIF4G1 PCID2 | 3.18e-06 | 754 | 124 | 13 | 35906200 | |
| Pubmed | KRT6A KRT6B MTERF1 SPTAN1 LARS1 CHD3 MDH2 SLC1A2 SLC25A22 PARP1 GUCY1A2 EIF4G1 EIF4G2 SYT1 PRKCE EIF4G3 HSPA2 UNC13A | 3.37e-06 | 1431 | 124 | 18 | 37142655 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RANBP2 NAA15 RARS1 SPTAN1 LARS1 IDH1 UNC45A MDH2 LAP3 PARP1 RUVBL1 EIF4G1 ZW10 EIF4G3 NMT1 HSPA2 | 3.48e-06 | 1149 | 124 | 16 | 35446349 |
| Pubmed | 3.66e-06 | 9 | 124 | 3 | 31960486 | ||
| Pubmed | Distinct developmental expression of synaptotagmin I and IX in the mouse brain. | 3.66e-06 | 9 | 124 | 3 | 16407767 | |
| Pubmed | 3.66e-06 | 9 | 124 | 3 | 8901523 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.08e-06 | 256 | 124 | 8 | 33397691 | |
| Pubmed | Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. | 5.21e-06 | 10 | 124 | 3 | 9914469 | |
| Pubmed | 5.33e-06 | 451 | 124 | 10 | 36168627 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 5.50e-06 | 123 | 124 | 6 | 26912792 | |
| Pubmed | RANBP2 RARS1 LARS1 CHD3 KRR1 MDH2 TRIP4 GATAD2B NCBP2 SLC25A22 PARP1 RUVBL1 RNPS1 POP1 EIF4G1 EIF4G2 HSPA2 | 5.51e-06 | 1335 | 124 | 17 | 29229926 | |
| Pubmed | RANBP2 SPTAN1 BSDC1 UNC45A CLCC1 IGBP1 SYNE2 EIF4G1 EIF4G2 ZW10 PCID2 | 6.42e-06 | 568 | 124 | 11 | 37774976 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RARS1 SPTAN1 LARS1 IDH1 MCCC1 MDH2 PARP1 AKAP9 RUVBL1 POP1 EIF4G1 NMT1 HSPA2 | 6.62e-06 | 807 | 124 | 13 | 30575818 |
| Pubmed | MGAT4B PSMG3 GRK5 BSDC1 CCDC80 CHD1L CPS1 NCBP2 ARL2 PIEZO2 CCZ1 WFIKKN1 RNF146 EIF4G3 HSPA2 CFAP46 | 7.03e-06 | 1215 | 124 | 16 | 15146197 | |
| Pubmed | 7.15e-06 | 11 | 124 | 3 | 10734137 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 NAA15 ANXA6 IDH1 MCCC1 MDH2 LAP3 CLCC1 PARP1 ARL2 IGBP1 RUVBL1 MTOR SYNE2 EIF4G1 EIF4G2 NMT1 | 7.51e-06 | 1367 | 124 | 17 | 32687490 |
| Pubmed | 8.06e-06 | 281 | 124 | 8 | 26725010 | ||
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 1.03e-05 | 384 | 124 | 9 | 31059266 | |
| Pubmed | KRT6A KRT6B RARS1 SPTAN1 LAMA3 MCCC1 PARP1 RUVBL1 KRT6C HSPA2 | 1.06e-05 | 488 | 124 | 10 | 31324722 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CCZ1B KRT6B RANBP2 HK2 RARS1 LARS1 CHD1L UNC45A SLC25A22 PARP1 IGBP1 RUVBL1 CCZ1 EIF4G1 HSPA2 PCID2 | 1.07e-05 | 1257 | 124 | 16 | 37317656 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT6A KRT6B CHD3 KRR1 TRIP4 GATAD2B PARP1 RUVBL1 KRT6C EIF4G1 EIF4G2 | 1.16e-05 | 605 | 124 | 11 | 28977666 |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22909319 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12709070 | ||
| Pubmed | Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer. | 1.26e-05 | 2 | 124 | 2 | 27055253 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 30154572 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10550543 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10550545 | ||
| Pubmed | PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent. | 1.26e-05 | 2 | 124 | 2 | 23110147 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27154627 | ||
| Pubmed | Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. | 1.26e-05 | 2 | 124 | 2 | 14504267 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9790766 | ||
| Pubmed | mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors. | 1.26e-05 | 2 | 124 | 2 | 32066462 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31999954 | ||
| Pubmed | Synaptotagmins 1 and 2 as mediators of rapid exocytosis at nerve terminals: the dyad hypothesis. | 1.26e-05 | 2 | 124 | 2 | 23648184 | |
| Pubmed | The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment. | 1.26e-05 | 2 | 124 | 2 | 33355125 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11489919 | ||
| Pubmed | eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. | 1.26e-05 | 2 | 124 | 2 | 10872469 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19769989 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10953016 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15452223 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 6207530 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 36456864 | ||
| Pubmed | Synaptotagmin I and II are present in distinct subsets of central synapses. | 1.26e-05 | 2 | 124 | 2 | 17492637 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24842055 | ||
| Pubmed | Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling. | 1.26e-05 | 2 | 124 | 2 | 34465625 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 14645153 | ||
| Pubmed | CHD1L: a new candidate gene for congenital anomalies of the kidneys and urinary tract (CAKUT). | 1.26e-05 | 2 | 124 | 2 | 22146311 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 32571876 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11118885 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11928817 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23132853 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22046423 | ||
| Pubmed | eIF4G-driven translation initiation of downstream ORFs in mammalian cells. | 1.26e-05 | 2 | 124 | 2 | 32941651 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15016848 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23662636 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31519767 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 2446925 | ||
| Pubmed | Inositol-1,3,4,5-tetrakisphosphate binding to C2B domain of IP4BP/synaptotagmin II. | 1.26e-05 | 2 | 124 | 2 | 7961887 | |
| Pubmed | Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. | 1.26e-05 | 2 | 124 | 2 | 15123599 | |
| Cytoband | 17p13.1 | 1.82e-05 | 118 | 124 | 5 | 17p13.1 | |
| Cytoband | 7q21-q22 | 3.21e-04 | 10 | 124 | 2 | 7q21-q22 | |
| GeneFamily | Synaptotagmins | 5.42e-05 | 17 | 80 | 3 | 765 | |
| GeneFamily | Keratins, type II | 2.26e-04 | 27 | 80 | 3 | 609 | |
| GeneFamily | C2 domain containing protein kinases | 8.50e-04 | 10 | 80 | 2 | 835 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 1.24e-03 | 12 | 80 | 2 | 660 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.96e-03 | 15 | 80 | 2 | 26 | |
| GeneFamily | Myosin heavy chains | 1.96e-03 | 15 | 80 | 2 | 1098 | |
| GeneFamily | Parkinson disease associated genes | 2.23e-03 | 16 | 80 | 2 | 672 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 2.83e-03 | 18 | 80 | 2 | 361 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 3.15e-03 | 19 | 80 | 2 | 131 | |
| GeneFamily | Transient receptor potential cation channels | 6.78e-03 | 28 | 80 | 2 | 249 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 7.26e-03 | 29 | 80 | 2 | 396 | |
| GeneFamily | PHD finger proteins | 7.43e-03 | 90 | 80 | 3 | 88 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 8.27e-03 | 31 | 80 | 2 | 357 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CCZ1B RANBP2 SPG7 PSMG3 LARS1 BSDC1 TRIP4 GATAD2B NCBP2 PARP1 IGBP1 VPS52 RAB9A RUVBL1 CCZ1 RNPS1 MTOR EIF4G2 SLC39A6 NMT1 | 4.52e-07 | 1158 | 123 | 20 | MM1338 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | RANBP2 SPG7 PSMG3 LARS1 BSDC1 TRIP4 GATAD2B NCBP2 PARP1 IGBP1 VPS52 RAB9A RUVBL1 CCZ1 RNPS1 MTOR EIF4G2 SLC39A6 NMT1 | 1.33e-06 | 1129 | 123 | 19 | M42508 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.98e-07 | 182 | 124 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.35e-06 | 197 | 124 | 7 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-06 | 197 | 124 | 7 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-06 | 42 | 124 | 4 | 56bbec86001d43cc2c71d4dcd70b22ea41963fad | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 178 | 124 | 6 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 178 | 124 | 6 | 6d9ecfaeb50d562899380de379ebf7b99fd8adc9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 178 | 124 | 6 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 178 | 124 | 6 | d3f518cd75b02e85d45cbb9b2eff30f0272512a8 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.50e-05 | 189 | 124 | 6 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 498bbe063bc75d323cb186a82cce122b511d2cff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 191 | 124 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 192 | 124 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 192 | 124 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.74e-05 | 194 | 124 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 194 | 124 | 6 | 592e8c4b73ba424a52305ac411ea9c0a2dc44467 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 195 | 124 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 195 | 124 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.79e-05 | 195 | 124 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 195 | 124 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 196 | 124 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.85e-05 | 196 | 124 | 6 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.85e-05 | 196 | 124 | 6 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 196 | 124 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 197 | 124 | 6 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 197 | 124 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.90e-05 | 197 | 124 | 6 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 197 | 124 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.95e-05 | 198 | 124 | 6 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.01e-05 | 199 | 124 | 6 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-dn_T|Leuk-UTI / Disease, condition lineage and cell class | 2.01e-05 | 199 | 124 | 6 | aa4d8ce8994e5032a33d5cc68c482882147cdc3b | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 124 | 6 | 5c0135d3cb6f7fa904e9760904dfe5f11c7e9102 | |
| ToppCell | proximal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 124 | 6 | 870ab11343711f64fe6d6a858fc420fe17f1636a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-05 | 200 | 124 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Cortical_neuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-05 | 200 | 124 | 6 | 458fb0f40c1720f1cacedf78c40bd059692bfc62 | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 124 | 6 | 22892afca3666e944102c231b3f10340d8391364 | |
| ToppCell | Basal_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 7.36e-05 | 155 | 124 | 5 | 30accc72a6a914ae0c4d52b373ea1c9a98efbf22 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.36e-05 | 155 | 124 | 5 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.55e-05 | 160 | 124 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.55e-05 | 160 | 124 | 5 | 7d34159363d274019e14549d1186c629ce990691 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.55e-05 | 160 | 124 | 5 | fe5fb0e7a79862f63529721f0a82f4f6d231d3ca | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.61e-05 | 164 | 124 | 5 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.61e-05 | 164 | 124 | 5 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 168 | 124 | 5 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 168 | 124 | 5 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.11e-04 | 169 | 124 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.17e-04 | 171 | 124 | 5 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 173 | 124 | 5 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 173 | 124 | 5 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 173 | 124 | 5 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 175 | 124 | 5 | 90302e8a44858ef3b2a165b88284d4788d591a99 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 175 | 124 | 5 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.30e-04 | 175 | 124 | 5 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.30e-04 | 175 | 124 | 5 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 175 | 124 | 5 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 177 | 124 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.37e-04 | 177 | 124 | 5 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-04 | 177 | 124 | 5 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 177 | 124 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 180 | 124 | 5 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 180 | 124 | 5 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-04 | 183 | 124 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 183 | 124 | 5 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 184 | 124 | 5 | e0e5a553fb8c0947679634396d20c2ca8455b932 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 184 | 124 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | CTRL-Lymphoid|CTRL / Disease state, Lineage and Cell class | 1.65e-04 | 184 | 124 | 5 | 26fb2c4e6cb9950c27eb15428e7e74e5abb4397d | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 184 | 124 | 5 | c3b848e1438a84b3fac8a4e40f3db478cc84d970 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 1.65e-04 | 184 | 124 | 5 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-04 | 185 | 124 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.69e-04 | 185 | 124 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.69e-04 | 185 | 124 | 5 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.77e-04 | 187 | 124 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 187 | 124 | 5 | 028e7d6e1211e123879d2f353dc32fae1185dd8e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 187 | 124 | 5 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.77e-04 | 187 | 124 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.82e-04 | 188 | 124 | 5 | de7cb273899d0e0748c85f45c6b5e7f0642ab057 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 188 | 124 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 188 | 124 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 188 | 124 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-04 | 188 | 124 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 188 | 124 | 5 | 524a12f433c7b6f33fad36c0716afa06cd3235e9 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.82e-04 | 188 | 124 | 5 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 188 | 124 | 5 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.82e-04 | 188 | 124 | 5 | f4734d5b703678670ece204a0519cf015e180a6e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 189 | 124 | 5 | de51fbd6fdb24fc4549393cf41a020005444b2aa | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 189 | 124 | 5 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 189 | 124 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 189 | 124 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 189 | 124 | 5 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 189 | 124 | 5 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 189 | 124 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 189 | 124 | 5 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 190 | 124 | 5 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | normal_Lung-Fibroblasts-Undetermined|normal_Lung / Location, Cell class and cell subclass | 1.91e-04 | 190 | 124 | 5 | 30d4658bcc6796f0cdf54cc029f4bb904b13ef66 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.91e-04 | 190 | 124 | 5 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.96e-05 | 50 | 72 | 5 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Drug | sodium dodecyl sulfate | 3.59e-08 | 91 | 124 | 8 | CID000008778 | |
| Drug | glutamate | HK2 RARS1 ABCB5 LARS1 IDH1 MCCC1 CPS1 MDH2 SLC1A2 CLCC1 SLC25A22 CATSPER1 MTOR EIF4G2 TRPV2 SYT1 PRKCE PRKCQ TRPM1 MAPK13 | 2.52e-07 | 962 | 124 | 20 | CID000000611 |
| Drug | ICE inhibitor | 1.39e-06 | 146 | 124 | 8 | CID000004330 | |
| Drug | morpholine-citrate | 2.42e-06 | 18 | 124 | 4 | CID000173845 | |
| Drug | SC-791 | 3.12e-06 | 6 | 124 | 3 | CID010291510 | |
| Drug | icilin | 4.67e-06 | 21 | 124 | 4 | CID000161930 | |
| Drug | eye gene | KRT6A MYH4 KRT6B RARS1 GUCY1A2 KRT6C MTOR PRKCE PRKCQ MAPK13 ALOX15B | 5.76e-06 | 369 | 124 | 11 | CID000004782 |
| Drug | adenosine 3',5'-cyclic phosphate | KRT6A KRT6B SYT2 IDH1 CPS1 MDH2 CLCC1 LATS1 AKAP9 GUCY1A2 KRT6C SYT1 PRKCE SYT5 PRKCQ MAPK13 SNRPG | 8.70e-06 | 907 | 124 | 17 | CID000000274 |
| Drug | Bhg-(2-1)fuc | 9.70e-06 | 25 | 124 | 4 | CID005287784 | |
| Drug | NSC99363 | 9.90e-06 | 90 | 124 | 6 | CID000414014 | |
| Drug | UDP-FGlc | 2.23e-05 | 62 | 124 | 5 | CID000125643 | |
| Drug | CGP57380 | 2.35e-05 | 31 | 124 | 4 | CID011644425 | |
| Drug | AGN 193109 | 2.35e-05 | 31 | 124 | 4 | CID000177238 | |
| Drug | aspartate | RARS1 LARS1 IDH1 MCCC1 CPS1 MDH2 SLC1A2 LAP3 CLCC1 SLC25A22 PARP1 SYT1 | 2.68e-05 | 518 | 124 | 12 | CID000000424 |
| Drug | dimethyl maleate | 2.94e-05 | 2 | 124 | 2 | ctd:C004780 | |
| Drug | baicalein | 3.04e-05 | 162 | 124 | 7 | CID005281605 | |
| Drug | tsuwabukinonol | 4.82e-05 | 37 | 124 | 4 | CID006440419 | |
| Drug | chrysarobin | 4.82e-05 | 37 | 124 | 4 | CID000068111 | |
| Disease | congenital myasthenic syndrome 7 (implicated_via_orthology) | 2.75e-07 | 4 | 122 | 3 | DOID:0110659 (implicated_via_orthology) | |
| Disease | neuromuscular junction disease (implicated_via_orthology) | 6.85e-07 | 5 | 122 | 3 | DOID:439 (implicated_via_orthology) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 3.71e-05 | 16 | 122 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | Early myoclonic encephalopathy | 5.07e-05 | 3 | 122 | 2 | cv:C0270855 | |
| Disease | Pachyonychia congenita syndrome | 1.01e-04 | 4 | 122 | 2 | cv:C0265334 | |
| Disease | retinoblastoma (is_marker_for) | 1.01e-04 | 4 | 122 | 2 | DOID:768 (is_marker_for) | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.01e-04 | 4 | 122 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.01e-04 | 4 | 122 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.01e-04 | 4 | 122 | 2 | C1721007 | |
| Disease | Pachyonychia Congenita | 1.68e-04 | 5 | 122 | 2 | C0265334 | |
| Disease | Kyphosis deformity of spine | 1.68e-04 | 5 | 122 | 2 | C0022821 | |
| Disease | hyperinsulinemic hypoglycemia (implicated_via_orthology) | 1.68e-04 | 5 | 122 | 2 | DOID:13317 (implicated_via_orthology) | |
| Disease | autoimmune disease (is_implicated_in) | 4.67e-04 | 8 | 122 | 2 | DOID:417 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | SPTAN1 HPSE SORCS1 PARP1 IGBP1 AKAP9 GUCY1A2 MTOR SYNE2 POP1 SLC39A6 SNCG CNGA2 | 5.15e-04 | 1074 | 122 | 13 | C0006142 |
| Disease | X-21467 measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0020007 | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 7.47e-04 | 10 | 122 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | stromal cell-derived factor 1 alpha measurement | 7.54e-04 | 43 | 122 | 3 | EFO_0008293 | |
| Disease | obsolete_red blood cell distribution width | KMT2B CPS1 TEX9 PGC F8 ARL17A RAB9A RUVBL1 RNF146 SYNE2 PRKCE PLA2G6 EIF4G3 NMT1 | 1.37e-03 | 1347 | 122 | 14 | EFO_0005192 |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.49e-03 | 14 | 122 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 1.49e-03 | 14 | 122 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | melanoma | 1.89e-03 | 126 | 122 | 4 | EFO_0000756 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.96e-03 | 16 | 122 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | thyroxine measurement, triiodothyronine measurement | 2.21e-03 | 17 | 122 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | hyperglycemia (implicated_via_orthology) | 2.21e-03 | 17 | 122 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 2.21e-03 | 17 | 122 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | COL3A1 ABCB5 IDH1 ARHGEF10L PARP1 AKAP9 GUCY1A2 EIF4G1 PRKCE | 2.61e-03 | 702 | 122 | 9 | C0009402 |
| Disease | Intellectual Disability | 2.63e-03 | 447 | 122 | 7 | C3714756 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.96e-03 | 69 | 122 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | susceptibility to mononucleosis measurement | 2.96e-03 | 69 | 122 | 3 | EFO_0008403 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.75e-03 | 75 | 122 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 4.07e-03 | 156 | 122 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 4.07e-03 | 156 | 122 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.07e-03 | 156 | 122 | 4 | C2585653 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDKFKGSLSEGMKVE | 501 | Q13523 | |
| MSLLCVGVKKAKFDG | 1 | Q9UPW8 | |
| NKLFKDDMEKLGLAI | 2251 | Q99996 | |
| LMKAAKSGTKDGLEK | 246 | Q9HCE6 | |
| EGTMLKRLIEKKFGT | 716 | Q8NEC5 | |
| TEKMKKGLSDFLGVI | 71 | Q9NW68 | |
| LIVTLKDGMLAEKGA | 591 | Q2M3G0 | |
| LDAKDKILKMNGETG | 1576 | Q8IYW2 | |
| GKLESLDGEELMKIK | 61 | Q5T2E6 | |
| MGNIFEKLFKSLLGK | 1 | Q8IVW1 | |
| KKLEAMLQAAAEGKG | 56 | Q9H694 | |
| LKLKEQMAFVGFKGS | 1316 | Q8WUJ3 | |
| GKFGMVLLKKTLQVE | 231 | Q76M96 | |
| DADAKALRKAMKGLG | 366 | P08133 | |
| AKGLMDIFGKGKETE | 136 | Q8NHQ8 | |
| TLKSGFEDMFAKKEG | 1531 | P49792 | |
| MAGKSSLFKVILLGD | 1 | P51151 | |
| DEVKAMIEKLGGKLT | 406 | P09874 | |
| MLGLDNAGKTTILKK | 21 | P36404 | |
| DMTKGLVLGIYSKEK | 31 | P28838 | |
| GEMALKDAKNKLEGL | 416 | P48668 | |
| KIEDFILHKMLGKGS | 376 | Q04759 | |
| KSFGLPGDMVLLEKK | 1541 | Q16787 | |
| MENKTFLEKLKFGIG | 456 | P30419 | |
| SKSGDIKKIIMGLDK | 61 | P52298 | |
| GFIGKMFKSLDLSLI | 301 | Q9UQ53 | |
| GEMALKDAKNKLEGL | 416 | P02538 | |
| DKSMFVKIKTLGIGA | 701 | O95835 | |
| TVGFLESELKKLLGM | 31 | Q5YKI7 | |
| IKVLGKGSFGKVMLA | 411 | Q02156 | |
| KNLGIGKVSSFEEKM | 301 | P40926 | |
| VKMAKEELLFGGKLS | 311 | P52789 | |
| AAKYKAMESKLLIGG | 511 | O14782 | |
| RFLVMASDLGKEKAK | 91 | Q8N140 | |
| TKMKEIAEAYLGGKV | 126 | P54652 | |
| KVFKGLDLLEKAAEM | 41 | P78318 | |
| GEMALKDAKNKLEGL | 416 | P04259 | |
| EVTRALMKILGKGKS | 296 | Q8NG81 | |
| MKGLTLNCLGKKEEA | 51 | Q6N069 | |
| KDGQKLTLLKEMLAG | 96 | Q9H936 | |
| MLTGKTLFKGKDYLD | 216 | O15264 | |
| KKLGALTAEEIALKM | 356 | Q13601 | |
| VGKGEFTKDVGLKEM | 1171 | P00451 | |
| AKKVKMGQLSLGLES | 311 | Q9UMN6 | |
| LKAANLEMFKGKGIE | 146 | Q8WXI9 | |
| DMKAALGKLIGKVAV | 296 | O60431 | |
| AIAKIKMLGNIKFIG | 201 | P78344 | |
| KMLGNIKFIGELGKL | 206 | P78344 | |
| AKMLKSFLKAGGEVI | 276 | Q9Y251 | |
| MKGLTLNCLGKKEEA | 51 | Q9BXJ9 | |
| GLLDLKSMIEKVTGK | 21 | P39877 | |
| KGKEEEILKALSGMC | 256 | Q99575 | |
| KSKVGDMLEKAAELL | 131 | Q5JVF3 | |
| KIIRDKGTMLGKIEF | 171 | P31327 | |
| EFMDKLGENLKIKLA | 396 | O75874 | |
| KKMKAINSLGAGIIE | 646 | Q8NB78 | |
| KKEKEMVGALVSDGL | 1971 | Q12873 | |
| KKGLEFKDGMNVLGL | 231 | P43004 | |
| LLFLELSTGKVGMLK | 761 | Q6MZW2 | |
| TFLKAMEDGGVKLLK | 151 | P86791 | |
| VLSGIKMAALEEGLK | 811 | Q86WJ1 | |
| KMAALEEGLKKIFLA | 816 | Q86WJ1 | |
| NMRDKLFLTGKLGSK | 456 | Q6UWU2 | |
| TFLKAMEDGGVKLLK | 151 | P86790 | |
| LGNIKFIGELFKLKM | 896 | Q04637 | |
| FVKAGDKVKAGDSLM | 661 | Q96RQ3 | |
| MKFRAKITGKGCLEL | 1 | Q8NHY5 | |
| VKKALKLMGSNEGEF | 1386 | P02461 | |
| KEMKLLEQAGSLKGS | 51 | Q9Y2S2 | |
| ATEMLIFGKKLTAGE | 296 | O75521 | |
| EKLGEKGKEIMTKYL | 96 | P34947 | |
| MDLSGISKQLVKKGV | 286 | Q9P225 | |
| GNIKFIGELFKLKML | 891 | O43432 | |
| LDKESGLLMFKGDKK | 1516 | Q9P2P1 | |
| AEKGFDETLAKEKGM | 241 | P42345 | |
| LGMIKAAGKKIYRLD | 251 | P33402 | |
| AFAEMKIKGLLDRKG | 191 | O15296 | |
| EAKNLKKMDVGGLSD | 296 | P21579 | |
| ILEAKNLKKMDVGGL | 291 | Q8N9I0 | |
| LEAKNLKKMDVGGLS | 261 | O00445 | |
| LGEGLKRSMDKLKEK | 466 | P54136 | |
| MDVFKKGFSIAKEGV | 1 | O76070 | |
| ASMELGKEAIAKGLL | 606 | Q2M3C7 | |
| MDLSGVKKKSLLGVK | 1 | Q15287 | |
| GSLFGGMVLKKFLKE | 61 | Q8N6T0 | |
| LMLIELKKKQEAGFA | 2156 | Q8WXH0 | |
| GVSFVDLMGIKALAK | 671 | Q7LBE3 | |
| LKMAKAGLLFGGEKS | 311 | Q2TB90 | |
| GIKDLSKVKLMRFDD | 1106 | Q9P2J5 | |
| KGKKNTEMLIAGFLY | 131 | Q9NTX7 | |
| TKVDALKKMLLDQGG | 81 | P39210 | |
| KVFFKAGLLGTLEEM | 766 | Q9Y623 | |
| ELAKTVFGAKELGKM | 716 | O60733 | |
| TIVDGKMGKGVSFKD | 296 | Q9UQ90 | |
| ILLTVFKMKSKEGRG | 221 | A6NMS3 | |
| LGDFAVLLKAGMTVK | 641 | Q13433 | |
| LDLVAKGDKMKIGCS | 451 | Q14246 | |
| GKGTGEFIKALMKEI | 316 | Q96S66 | |
| DIGKEMYIIKEGKLA | 486 | Q16280 | |
| FQEKEKELGKAKLMG | 346 | Q7Z4H8 | |
| LMGVEDTAKKGFFSK | 321 | Q8N1B4 | |
| LKGMLKKFKEDLRGE | 321 | Q9C029 | |
| FKSIRETMKEKGLLG | 26 | P20142 | |
| KFMDKKLSLKLNGGR | 11 | P62308 | |
| KYDLKKNILGDVMSG | 101 | P50443 | |
| MKGLNGKVSDLEKAA | 1951 | Q13813 | |
| MTGLKKEKLEDLGLK | 766 | Q9H5I5 | |
| GKTCLMKAVLNLKDG | 116 | Q9Y5S1 | |
| RKSLFGKKNMLVGEV | 976 | Q6P2S7 | |
| DLKMFLLSKGASKEV | 106 | Q99551 | |
| LMSLKRKEKGVIFGS | 101 | Q14CB8 | |
| MKLKDSLFDLDGPKV | 131 | Q9BUL5 | |
| IKSKKMAGRAVLLAG | 56 | Q9Y265 | |
| KNGLKDLFKVGLMTK | 386 | Q9Y2C9 | |
| LALKGGKRTIMKLEA | 966 | Q9H6N6 | |
| LKQVFGKGLIKAAMT | 116 | Q7Z4N2 | |
| DVLKDDKMGLKFLGT | 461 | Q96NZ8 | |
| DKMGLKFLGTKYLEV | 466 | Q96NZ8 | |
| FVGEKVDEEGLKKLM | 46 | P29034 | |
| LLKKLMSGVENSGKV | 226 | Q15650 | |
| GAELALLLGKDMFSK | 586 | A2RRH5 | |
| EVAGIKGMFLANKKI | 471 | Q8WY21 | |
| CLKLMLKKSGLQGDA | 871 | Q9NVE5 | |
| GELMIGFKKQLKLID | 346 | Q8N6V9 | |
| LQVMFDALKEGVKKG | 261 | Q9H3U1 | |
| KEMRFLKGDTTDLLK | 376 | O43264 | |
| LLAVAVKDKSMEGLK | 96 | Q9BT73 | |
| DEVLKDEKMGLKFLG | 486 | Q8TEU8 |